Bimekizumab Maintenance of Response and Safety in Patients with Moderate-to-Severe Plaque Psoriasis: Results from the Open-Label Extension Period (Weeks 48–144) of the BE RADIANT Phase 3b Trial
Authors: Bruce Strober, Luis Puig, Andrew Blauvelt, Diamant Thaçi, Boni Elewski, Maggie Wang, Veerle Vanvoorden, Delphine Deherder, Fabienne Staelens, Susanne Wiegratz, Carle Paul
